Vertex Pharmaceuticals

By person

23 insiders · 95 transactions

31.8×

Reshma Kewalramani holds 31.8 times base salary in stock. $51.01M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what Reshma Kewalramani last reported holding, valued at $519.00, the price Common Stock was last bought or sold at on the open market here, on 2 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

LEIDEN JEFFREY M

Executive Chairman

—

$60.94M (17) scheduled

−$60.94M

34,797

0.0137%

$18.06M

+248.2%

Sachdev Amit

EVP Chief Patient & Ext Af Off

—

$28.38M (9) scheduled

−$28.38M

66,512

0.0262%

$34.52M

+31.0%

Kewalramani Reshma

CEO & President

—

$19.74M (13) scheduled

−$19.74M

98,278

0.0388%

$51.01M

+8.0%

Bozic Carmen

EVP and CMO

—

$11.31M (10) scheduled

−$11.31M

15,337

0.0061%

$7.96M

−34.1%

WAGNER CHARLES F JR

EVP, CO & FO

—

$10.78M (3) scheduled

−$10.78M

47,042

0.0186%

$24.41M

−0.3%

Tatsis Ourania

EVP, Chief Reg. & Quality Off.

—

$6.51M (8) scheduled

−$6.51M

53,572

0.0211%

$27.80M

+8.9%

McKechnie Duncan

EVP, Chief Commercial Officer

—

$5.66M (5) scheduled

−$5.66M

11,001

0.0043%

$5.71M

−32.1%

Biller Jonathan

EVP and Chief Legal Officer

—

$4.08M (7) scheduled

−$4.08M

13,659

0.0054%

$7.09M

−25.3%

Atkinson Edward Morrow III

EVP, Chief Technical Ops. Off.

—

$3.60M (5) scheduled

−$3.60M

18,432

0.0073%

$9.57M

+15.4%

Bunnage Mark E.

EVP, Chief Scientific Officer

—

$3.00M (5) scheduled

−$3.00M

7,284

0.0029%

$3.78M

−54.7%

Liu Joy

EVP and Chief Legal Officer

—

$2.13M (5) scheduled

−$2.13M

19,131

0.0075%

$9.93M

−19.5%

Ambrose Kristen

SVP & Chief Accounting Officer

—

$1.98M (5) scheduled

−$1.98M

11,624

0.0046%

$6.03M

+55.0%

Bhatia Sangeeta N.

Director

—

$267.75K (2) scheduled

−$267.75K

4,924

0.0019%

$2.56M

+11.0%

Arbuckle Stuart A

EVP, COO

—

63,368

0.0250%

$32.89M

+27.4%

SACHS BRUCE I

Director

—

39,000

0.0154%

$20.24M

−2.5%

ALTSHULER DAVID

EVP, Chief Scientific Officer

—

34,477

0.0136%

$17.89M

+33.2%

van Grunsven Jasper

EVP, CP and NPPO

—

8,682

0.0034%

$4.51M

—

Garber Alan M

Director

—

7,344

0.0029%

$3.81M

+13.4%

CARNEY LLOYD

Director

—

6,315

0.0025%

$3.28M

−0.1%

MCKENZIE DIANA

Director

—

2,378

0.0009%

$1.23M

−2.4%

Thornberry Nancy

Director

—

2,109

0.0008%

$1.09M

+28.8%

Upadhyay Suketu

Director

—

1,558

0.0006%

$808.60K

−39.1%

Schneider Jennifer

Director

—

1,394

0.0005%

$723.49K

+51.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

4,237

$471.43

$2.00M

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

11,712

$470.54

$5.51M

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

7,241

$469.61

$3.40M

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

19,662

$468.57

$9.21M

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

10,263

$467.75

$4.80M

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

1,848

$465.80

$860.80K

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

2,730

$465.05

$1.27M

Sachdev Amit

19 Feb 2026

EVP Chief Patient & Ext Af Off

Sold after exercise

920

$463.91

$426.80K

WAGNER CHARLES F JR

6 Jan 2026

EVP, CO & FO

Sold after exercise

9,532

$461.00

$4.39M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

2,070

$455.22

$942.31K

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

10,360

$453.34

$4.70M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

15,681

$452.20

$7.09M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

5,809

$451.20

$2.62M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

5,880

$449.84

$2.65M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

2,320

$448.78

$1.04M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

1,152

$447.05

$515.00K

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

7,899

$445.56

$3.52M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

4,352

$444.36

$1.93M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

2,469

$443.21

$1.09M

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

1,320

$441.26

$582.46K

LEIDEN JEFFREY M

3 Dec 2025

Executive Chairman

Sold after exercise

4,469

$440.40

$1.97M

LEIDEN JEFFREY M

14 Nov 2025

Executive Chairman

Sold after exercise

$442.00

$17.68K

LEIDEN JEFFREY M

14 Nov 2025

Executive Chairman

Sold after exercise

21,330

$441.35

$9.41M

LEIDEN JEFFREY M

14 Nov 2025

Executive Chairman

Sold after exercise

32,234

$440.30

$14.19M

LEIDEN JEFFREY M

13 Nov 2025

Executive Chairman

Sold after exercise

1,160

$441.05

$511.62K

LEIDEN JEFFREY M

13 Nov 2025

Executive Chairman

Sold after exercise

18,528

$440.22

$8.16M

Show all 95 transactions →

By person

Individual transactions

What was left out